Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 1789395, 10 pages
https://doi.org/10.1155/2017/1789395
Review Article

Muscle Lipid Metabolism: Role of Lipid Droplets and Perilipins

1Departamento de Tecnología Médica, Facultad de Medicina, Universidad de Chile, Santiago, Chile
2CIDIS-AC, Escuela de Medicina, Universidad de Valparaiso, Valparaiso, Chile
3Center for Molecular Studies of the Cell, Facultad de Medicina, Universidad de Chile, Santiago, Chile

Correspondence should be addressed to Alejandra Espinosa; lc.elihcu.dem@asonipseb

Received 6 January 2017; Revised 19 April 2017; Accepted 26 April 2017; Published 6 June 2017

Academic Editor: Erick O. Hernández-Ochoa

Copyright © 2017 Pablo Esteban Morales et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Arroyo-Johnson and K. D. Mincey, “Obesity epidemiology worldwide,” Gastroenterology Clinics of North America, vol. 45, no. 4, pp. 571–579, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, “Global estimates of diabetes prevalence for 2013 and projections for 2035,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Jallut, A. Golay, R. Munger et al., “Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism,” Metabolism, vol. 39, no. 10, pp. 1068–1075, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. D. P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham, and A. H. Anis, “The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis,” BMC Public Health, vol. 9, p. 88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. M. Reaven, C. Hollenbeck, C. Y. Jeng, M. S. Wu, and Y. D. Chen, “Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM,” Diabetes, vol. 37, no. 8, pp. 1020–1024, 1988. View at Publisher · View at Google Scholar
  6. A. Golay, A. L. Swislocki, Y. D. Chen, and G. M. Reaven, “Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals,” Metabolism, vol. 36, no. 7, pp. 692–696, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar
  8. E. Cersosimo, C. Triplitt, L. J. Mandarino, and D. F. RA, “Pathogenesis of type 2 diabetes mellitus,” in Endotext, L. J. De Groot, G. Chrousos, K. Dungan et al., Eds., MDText.com, Inc., South Dartmouth (MA), 2000. View at Google Scholar
  9. R. A. DeFronzo, R. Gunnarsson, O. Bjorkman, M. Olsson, and J. Wahren, “Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus,” The Journal of Clinical Investigation, vol. 76, no. 1, pp. 149–155, 1985. View at Publisher · View at Google Scholar
  10. R. A. DeFronzo, E. Jacot, E. Jequier, E. Maeder, J. Wahren, and J. P. Felber, “The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization,” Diabetes, vol. 30, no. 12, pp. 1000–1007, 1981. View at Publisher · View at Google Scholar
  11. E. Ferrannini, O. Bjorkman, and G. A. Reichard JrA. Pilo, M. Olsson, J. Wahren, and R. A. DeFronzo, “The disposal of an oral glucose load in healthy subjects. A quantitative study,” Diabetes, vol. 34, no. 6, pp. 580–588, 1985. View at Publisher · View at Google Scholar
  12. D. E. James, M. Strube, and M. Mueckler, “Molecular cloning and characterization of an insulin-regulatable glucose transporter,” Nature, vol. 338, no. 6210, pp. 83–87, 1989. View at Publisher · View at Google Scholar
  13. M. J. Birnbaum, “Identification of a novel gene encoding an insulin-responsive glucose transporter protein,” Cell, vol. 57, no. 2, pp. 305–315, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Huang and M. P. Czech, “The GLUT4 glucose transporter,” Cell Metabolism, vol. 5, no. 4, pp. 237–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. F. S. Thong, C. B. Dugani, and A. Klip, “Turning signals on and off: GLUT4 traffic in the insulin-signaling highway,” Physiology (Bethesda), vol. 20, no. 4, pp. 271–284, 2005. View at Publisher · View at Google Scholar
  16. E. Fraze, C. C. Donner, A. L. Swislocki, Y. A. Chiou, Y. D. Chen, and G. M. Reaven, “Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 61, no. 5, pp. 807–811, 1985. View at Publisher · View at Google Scholar · View at Scopus
  17. W. L. Holland, J. T. Brozinick, L. P. Wang et al., “Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance,” Cell Metabolism, vol. 5, no. 3, pp. 167–179, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Krssak, K. Falk Petersen, A. Dresner et al., “Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study,” Diabetologia, vol. 42, no. 1, pp. 113–116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Yu, Y. Chen, G. W. Cline et al., “Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle,” The Journal of Biological Chemistry, vol. 277, no. 52, pp. 50230–50236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. S. I. Itani, N. B. Ruderman, F. Schmieder, and G. Boden, “Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha,” Diabetes, vol. 51, no. 7, pp. 2005–2011, 2002. View at Publisher · View at Google Scholar
  21. M. W. Hulver, J. R. Berggren, R. N. Cortright et al., “Skeletal muscle lipid metabolism with obesity,” American Journal of Physiology. Endocrinology and Metabolism, vol. 284, no. 4, pp. E741–E747, 2003. View at Publisher · View at Google Scholar
  22. L. Sylow, M. Kleinert, E. A. Richter, and T. E. Jensen, “Exercise-stimulated glucose uptake - regulation and implications for glycaemic control,” Nature Reviews. Endocrinology, vol. 13, no. 3, pp. 133–148, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Eaton, “Control of mitochondrial beta-oxidation flux,” Progress in Lipid Research, vol. 41, no. 3, pp. 197–239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. J. Peters, D. J. Dyck, A. Bonen, and L. L. Spriet, “Effects of epinephrine on lipid metabolism in resting skeletal muscle,” The American Journal of Physiology, vol. 275, no. 2 Part 1, pp. E300–E309, 1998. View at Google Scholar
  25. D. J. Dyck and A. Bonen, “Muscle contraction increases palmitate esterification and oxidation and triacylglycerol oxidation,” The American Journal of Physiology, vol. 275, no. 5 Part 1, pp. E888–E896, 1998. View at Google Scholar
  26. J. J. Dube, P. M. Coen, G. DiStefano et al., “Effects of acute lipid overload on skeletal muscle insulin resistance, metabolic flexibility, and mitochondrial performance,” American Journal of Physiology. Endocrinology and Metabolism, vol. 307, no. 12, pp. E1117–E1124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Ukropcova, M. McNeil, O. Sereda et al., “Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor,” The Journal of Clinical Investigation, vol. 115, no. 7, pp. 1934–1941, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. T. McFarlan, Y. Yoshida, S. S. Jain et al., “In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation,” The Journal of Biological Chemistry, vol. 287, no. 28, pp. 23502–23516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. G. S. Hotamisligil and D. A. Bernlohr, “Metabolic functions of FABPs—mechanisms and therapeutic implications,” Nature Reviews. Endocrinology, vol. 11, no. 10, pp. 592–605, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kazantzis and A. Stahl, “Fatty acid transport proteins, implications in physiology and disease,” Biochimica et Biophysica Acta, vol. 1821, no. 5, pp. 852–857, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. J. Luiken, D. P. Koonen, J. Willems et al., “Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36,” Diabetes, vol. 51, no. 10, pp. 3113–3119, 2002. View at Publisher · View at Google Scholar
  32. S. S. Jain, J. J. Luiken, L. A. Snook et al., “Fatty acid transport and transporters in muscle are critically regulated by Akt2,” FEBS Letters, vol. 589, no. 19 Part B, pp. 2769–2775, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. B. K. Smith, A. Bonen, and G. P. Holloway, “A dual mechanism of action for skeletal muscle FAT/CD36 during exercise,” Exercise and Sport Sciences Reviews, vol. 40, no. 4, pp. 211–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Jeppesen, P. H. Albers, A. J. Rose et al., “Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent,” Journal of Lipid Research, vol. 52, no. 4, pp. 699–711, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Bonen, S. S. Jain, L. A. Snook et al., “Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats,” Diabetologia, vol. 58, no. 10, pp. 2381–2391, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. J. J. Luiken, D. Miskovic, Y. Arumugam, J. F. Glatz, and A. Bonen, “Skeletal muscle fatty acid transport and transporters,” International Journal of Sport Nutrition and Exercise Metabolism, vol. 11, no. s1, pp. S92–S96, 2001. View at Google Scholar
  37. Z. Jia, Z. Pei, D. Maiguel, C. J. Toomer, and P. A. Watkins, “The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers?” Journal of Molecular Neuroscience, vol. 33, no. 1, pp. 25–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. L. E. Stefanyk, A. Bonen, and D. J. Dyck, “Insulin and contraction-induced movement of fatty acid transport proteins to skeletal muscle transverse-tubules is distinctly different than to the sarcolemma,” Metabolism, vol. 61, no. 11, pp. 1518–1522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. G. P. Holloway, C. J. Chou, J. Lally et al., “Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance,” Diabetologia, vol. 54, no. 6, pp. 1457–1467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. J. A. Kanaley, S. Shadid, M. T. Sheehan, Z. Guo, and M. D. Jensen, “Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans,” The Journal of Physiology, vol. 587, Part 24, pp. 5939–5950, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Brøns and L. G. Grunnet, “MECHANISMS IN ENDOCRINOLOGY: skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?” European Journal of Endocrinology, vol. 176, no. 2, pp. R67–R78, 2017. View at Publisher · View at Google Scholar
  42. S. Jacob, J. Machann, K. Rett et al., “Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects,” Diabetes, vol. 48, no. 5, pp. 1113–1119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Brioche, A. F. Pagano, G. Py, and A. Chopard, “Muscle wasting and aging: experimental models, fatty infiltrations, and prevention,” Molecular Aspects of Medicine, vol. 50, pp. 56–87, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Bosma, “Lipid droplet dynamics in skeletal muscle,” Experimental Cell Research, vol. 340, no. 2, pp. 180–186, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Ghosh, N. Patel, K. Jiang et al., “Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells,” Endocrinology, vol. 148, no. 3, pp. 1359–1366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Hoeg, C. Roepstorff, M. Thiele, E. A. Richter, J. F. Wojtaszewski, and B. Kiens, “Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling,” Journal of Applied Physiology (Bethesda, Md.: 1985), vol. 107, no. 3, pp. 824–831, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. L. J. van Loon, R. Koopman, R. Manders, W. van der Weegen, G. P. van Kranenburg, and H. A. Keizer, “Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes,” American Journal of Physiology. Endocrinology and Metabolism, vol. 287, no. 3, pp. E558–E565, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. J. J. Dube, F. Amati, M. Stefanovic-Racic, F. G. Toledo, S. E. Sauers, and B. H. Goodpaster, “Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete’s paradox revisited,” American Journal of Physiology. Endocrinology and Metabolism, vol. 294, no. 5, pp. E882–E888, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. E. W. Kraegen, A. K. Saha, E. Preston et al., “Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats,” American Journal of Physiology. Endocrinology and Metabolism, vol. 290, no. 3, pp. E471–E479, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Park, V. Kaddai, J. Ching et al., “A role for ceramides, but not sphingomyelins, as antagonists of insulin signaling and mitochondrial metabolism in C2C12 myotubes,” The Journal of Biological Chemistry, vol. 291, no. 46, pp. 23978–23988, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. J. A. Chavez and S. A. Summers, “Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes,” Archives of Biochemistry and Biophysics, vol. 419, no. 2, pp. 101–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Amati, J. J. Dube, E. Alvarez-Carnero et al., “Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?” Diabetes, vol. 60, no. 10, pp. 2588–2597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Zechner, P. C. Kienesberger, G. Haemmerle, R. Zimmermann, and A. Lass, “Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores,” Journal of Lipid Research, vol. 50, no. 1, pp. 3–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. R. C. Meex, A. J. Hoy, R. M. Mason et al., “ATGL-mediated triglyceride turnover and the regulation of mitochondrial capacity in skeletal muscle,” American Journal of Physiology. Endocrinology and Metabolism, vol. 308, no. 11, pp. E960–E970, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Biswas, M. Ghosh, S. Kumar, and P. Chakrabarti, “PPARα-ATGL pathway improves muscle mitochondrial metabolism: implication in aging,” The FASEB Journal, vol. 30, no. 11, pp. 3822–3834, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. P. C. Turnbull, A. B. Longo, S. V. Ramos, B. D. Roy, W. E. Ward, and S. J. Peters, “Increases in skeletal muscle ATGL and its inhibitor G0S2 following 8 weeks of endurance training in metabolically different rat skeletal muscles,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, vol. 310, no. 2, pp. R125–R133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Aquilano, S. Baldelli, L. La Barbera, D. Lettieri Barbato, G. Tatulli, and M. R. Ciriolo, “Adipose triglyceride lipase decrement affects skeletal muscle homeostasis during aging through FAs-PPARalpha-PGC-1alpha antioxidant response,” Oncotarget, vol. 7, no. 17, pp. 23019–23032, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Lass, R. Zimmermann, G. Haemmerle et al., “Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman syndrome,” Cell Metabolism, vol. 3, no. 5, pp. 309–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. R. R. Mason, R. C. Meex, A. P. Russell, B. J. Canny, and M. J. Watt, “Cellular localization and associations of the major lipolytic proteins in human skeletal muscle at rest and during exercise,” PloS One, vol. 9, no. 7, article e103062, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. P. M. Badin, C. Loubiere, M. Coonen et al., “Regulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58,” Journal of Lipid Research, vol. 53, no. 5, pp. 839–848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Xie, A. K. Kadegowda, Y. Ma et al., “Muscle-specific deletion of comparative gene identification-58 (CGI-58) causes muscle steatosis but improves insulin sensitivity in male mice,” Endocrinology, vol. 156, no. 5, pp. 1648–1658, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. B. G. Nur, P. Gencpinar, A. Yuzbasioglu, S. D. Emre, and E. Mihci, “Chanarin-Dorfman syndrome: genotype-phenotype correlation,” European Journal of Medical Genetics, vol. 58, no. 4, pp. 238–242, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Langfort, T. Ploug, J. Ihlemann, M. Saldo, C. Holm, and H. Galbo, “Expression of hormone-sensitive lipase and its regulation by adrenaline in skeletal muscle,” The Biochemical Journal, vol. 340, Part 2, pp. 459–465, 1999. View at Google Scholar
  64. J. Langfort, T. Ploug, J. Ihlemann, C. Holm, and H. Galbo, “Stimulation of hormone-sensitive lipase activity by contractions in rat skeletal muscle,” The Biochemical Journal, vol. 351, Part 1, pp. 207–214, 2000. View at Google Scholar
  65. M. J. Watt, A. G. Holmes, S. K. Pinnamaneni et al., “Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue,” American Journal of Physiology. Endocrinology and Metabolism, vol. 290, no. 3, pp. E500–E508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. C. W. Wang, “Lipid droplets, lipophagy, and beyond,” Biochimica et Biophysica Acta, vol. 1861, no. 8 Part B, pp. 793–805, 2016. View at Publisher · View at Google Scholar · View at Scopus
  67. T. L. Vrablik, V. A. Petyuk, E. M. Larson, R. D. Smith, and J. L. Watts, “Lipidomic and proteomic analysis of Caenorhabditis elegans lipid droplets and identification of ACS-4 as a lipid droplet-associated protein,” Biochimica et Biophysica Acta, vol. 1851, no. 10, pp. 1337–1345, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Mishra, R. Khaddaj, S. Cottier, V. Stradalova, C. Jacob, and R. Schneiter, “Mature lipid droplets are accessible to ER luminal proteins,” Journal of Cell Science, vol. 129, no. 20, pp. 3803–3815, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. P. E. Bickel, J. T. Tansey, and M. A. Welte, “PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores,” Biochimica et Biophysica Acta, vol. 1791, no. 6, pp. 419–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. N. E. Wolins, D. L. Brasaemle, and P. E. Bickel, “A proposed model of fat packaging by exchangeable lipid droplet proteins,” FEBS Letters, vol. 580, no. 23, pp. 5484–5491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. N. E. Wolins, B. K. Quaynor, J. R. Skinner, M. J. Schoenfish, A. Tzekov, and P. E. Bickel, “S3-12, adipophilin, and TIP47 package lipid in adipocytes,” The Journal of Biological Chemistry, vol. 280, no. 19, pp. 19146–19155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Chen, H. Wang, X. Li, N. Li, G. Xu, and Q. Meng, “PLIN1 deficiency affects testicular gene expression at the meiotic stage in the first wave of spermatogenesis,” Gene, vol. 543, no. 2, pp. 212–219, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. R. E. MacPherson and S. J. Peters, “Piecing together the puzzle of perilipin proteins and skeletal muscle lipolysis,” Applied Physiology, Nutrition, and Metabolism, vol. 40, no. 7, pp. 641–651, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Minnaard, P. Schrauwen, G. Schaart et al., “Adipocyte differentiation-related protein and OXPAT in rat and human skeletal muscle: involvement in lipid accumulation and type 2 diabetes mellitus,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 10, pp. 4077–4085, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. R. E. MacPherson, S. V. Ramos, R. Vandenboom, B. D. Roy, and S. J. Peters, “Skeletal muscle PLIN proteins, ATGL and CGI-58, interactions at rest and following stimulated contraction,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, vol. 304, no. 8, pp. R644–R650, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. R. E. Macpherson, R. Vandenboom, B. D. Roy, and S. J. Peters, “Skeletal muscle PLIN3 and PLIN5 are serine phosphorylated at rest and following lipolysis during adrenergic or contractile stimulation,” Physiological Reports, vol. 1, no. 4, article e00084, 2013. View at Publisher · View at Google Scholar
  77. M. Bosma, M. K. Hesselink, L. M. Sparks et al., “Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levels,” Diabetes, vol. 61, no. 11, pp. 2679–2690, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Conte, F. Vasuri, G. Trisolino et al., “Increased Plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness,” PloS One, vol. 8, no. 8, p. e73709, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. M. B. Stout, J. N. Justice, B. J. Nicklas, and J. L. Kirkland, “Physiological aging: links among adipose tissue dysfunction, diabetes, and frailty,” Physiology (Bethesda), vol. 32, no. 1, pp. 9–19, 2017. View at Publisher · View at Google Scholar
  80. M. Kleinert, B. L. Parker, R. Chaudhuri et al., “mTORC2 and AMPK differentially regulate muscle triglyceride content via perilipin 3,” Molecular Metabolism, vol. 5, no. 8, pp. 646–655, 2016. View at Publisher · View at Google Scholar · View at Scopus
  81. J. D. Covington, R. C. Noland, R. C. Hebert et al., “Perilipin 3 differentially regulates skeletal muscle lipid oxidation in active, sedentary, and type 2 diabetic males,” The Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 10, pp. 3683–3692, 2015. View at Publisher · View at Google Scholar · View at Scopus
  82. S. V. Ramos, P. C. Turnbull, R. E. MacPherson, P. J. LeBlanc, W. E. Ward, and S. J. Peters, “Changes in mitochondrial perilipin 3 and perilipin 5 protein content in rat skeletal muscle following endurance training and acute stimulated contraction,” Experimental Physiology, vol. 100, no. 4, pp. 450–462, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. K. Hsieh, Y. K. Lee, C. Londos, B. M. Raaka, K. T. Dalen, and A. R. Kimmel, “Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-ester-specific intracellular lipid storage droplets,” Journal of Cell Science, vol. 125, Part 17, pp. 4067–4076, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Pourteymour, S. Lee, T. M. Langleite et al., “Perilipin 4 in human skeletal muscle: localization and effect of physical activity,” Physiological Reports, vol. 3, no. 8, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. N. E. Wolins, B. K. Quaynor, J. R. Skinner et al., “OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization,” Diabetes, vol. 55, no. 12, pp. 3418–3428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. C. Laurens, V. Bourlier, A. Mairal et al., “Perilipin 5 fine-tunes lipid oxidation to metabolic demand and protects against lipotoxicity in skeletal muscle,” Scientific Reports, vol. 6, p. 38310, 2016. View at Publisher · View at Google Scholar · View at Scopus
  87. S. V. Ramos, R. E. MacPherson, P. C. Turnbull et al., “Higher PLIN5 but not PLIN3 content in isolated skeletal muscle mitochondria following acute in vivo contraction in rat hindlimb,” Physiological Reports, vol. 2, no. 10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Bosma, L. M. Sparks, G. J. Hooiveld et al., “Overexpression of PLIN5 in skeletal muscle promotes oxidative gene expression and intramyocellular lipid content without compromising insulin sensitivity,” Biochimica et Biophysica Acta, vol. 1831, no. 4, pp. 844–852, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. L. A. Harris, J. R. Skinner, T. M. Shew, T. A. Pietka, N. A. Abumrad, and N. E. Wolins, “Perilipin 5-driven lipid droplet accumulation in skeletal muscle stimulates the expression of fibroblast growth factor 21,” Diabetes, vol. 64, no. 8, pp. 2757–2768, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Casas, R. Figueroa, G. Jorquera, M. Escobar, J. Molgó, and E. Jaimovich, “IP(3)-dependent, post-tetanic calcium transients induced by electrostimulation of adult skeletal muscle fibers,” The Journal of General Physiology, vol. 136, no. 4, pp. 455–467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. S. V. Ramos, P. C. Turnbull, and R. E. MacPherson, “Adipose tissue depot specific differences of PLIN protein content in endurance trained rats,” Adipocytes, vol. 5, no. 2, pp. 212–223, 2016. View at Publisher · View at Google Scholar
  92. R. E. MacPherson, E. A. Herbst, E. J. Reynolds, R. Vandenboom, B. D. Roy, and S. J. Peters, “Subcellular localization of skeletal muscle lipid droplets and PLIN family proteins OXPAT and ADRP at rest and following contraction in rat soleus muscle,” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, vol. 302, no. 1, pp. R29–R36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Prats, M. Donsmark, K. Qvortrup et al., “Decrease in intramuscular lipid droplets and translocation of HSL in response to muscle contraction and epinephrine,” Journal of Lipid Research, vol. 47, no. 11, pp. 2392–2399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Roepstorff, B. Vistisen, M. Donsmark et al., “Regulation of hormone-sensitive lipase activity and Ser563 and Ser565 phosphorylation in human skeletal muscle during exercise,” The Journal of Physiology, vol. 560, Part 2, pp. 551–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. R. Rinnankoski-Tuikka, J. J. Hulmi, S. Torvinen et al., “Lipid droplet-associated proteins in high-fat fed mice with the effects of voluntary running and diet change,” Metabolism, vol. 63, no. 8, pp. 1031–1040, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Espinosa, C. Campos, A. Diaz-Vegas et al., “Insulin-dependent H2O2 production is higher in muscle fibers of mice fed with a high-fat diet,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15740–15754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Kuramoto, T. Okamura, T. Yamaguchi et al., “Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation,” The Journal of Biological Chemistry, vol. 287, no. 28, pp. 23852–23863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Boucher, A. Kleinridders, and C. R. Kahn, “Insulin receptor signaling in normal and insulin-resistant states,” Cold Spring Harbor Perspectives in Biology, vol. 6, no. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. S. A. Summers, L. A. Garza, H. Zhou, and M. J. Birnbaum, “Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide,” Molecular and Cellular Biology, vol. 18, no. 9, pp. 5457–5464, 1998. View at Publisher · View at Google Scholar
  100. R. Ragheb, G. M. Shanab, A. M. Medhat, D. M. Seoudi, K. Adeli, and I. G. Fantus, “Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways,” Biochemical and Biophysical Research Communications, vol. 389, no. 2, pp. 211–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Senthivinayagam, A. L. McIntosh, K. C. Moon, and B. P. Atshaves, “Plin2 inhibits cellular glucose uptake through interactions with SNAP23, a SNARE complex protein,” PloS One, vol. 8, no. 9, p. e73696, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. S. S. Bakke, Y. Z. Feng, N. Nikolic et al., “Myotubes from severely obese type 2 diabetic subjects accumulate less lipids and show higher lipolytic rate than myotubes from severely obese non-diabetic subjects,” PloS One, vol. 10, no. 3, article e0119556, 2015. View at Publisher · View at Google Scholar · View at Scopus
  103. N. Billecke, M. Bosma, W. Rock et al., “Perilipin 5 mediated lipid droplet remodelling revealed by coherent Raman imaging,” Integrative Biology (Camb), vol. 7, no. 4, pp. 467–476, 2015. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Gemmink, M. Bosma, H. J. Kuijpers et al., “Decoration of intramyocellular lipid droplets with PLIN5 modulates fasting-induced insulin resistance and lipotoxicity in humans,” Diabetologia, vol. 59, no. 5, pp. 1040–1048, 2016. View at Publisher · View at Google Scholar · View at Scopus
  105. E. Masiero, L. Agatea, C. Mammucari et al., “Autophagy is required to maintain muscle mass,” Cell Metabolism, vol. 10, no. 6, pp. 507–515, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. A. D. Barbosa, D. B. Savage, and S. Siniossoglou, “Lipid droplet-organelle interactions: emerging roles in lipid metabolism,” Current Opinion in Cell Biology, vol. 35, pp. 91–97, 2015. View at Publisher · View at Google Scholar · View at Scopus
  107. G. K. Sakellariou, T. Pearson, A. P. Lightfoot et al., “Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy,” Scientific Reports, vol. 6, p. 33944, 2016. View at Publisher · View at Google Scholar · View at Scopus
  108. J. Sarparanta, M. Garcia-Macia, and R. Singh, “Autophagy and mitochondria in obesity and type 2 diabetes,” Current Diabetes Reviews, vol. 12, pp. 1–17, 2016. View at Publisher · View at Google Scholar
  109. C. E. Fealy, A. Mulya, N. Lai, and J. P. Kirwan, “Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle,” Journal of Applied Physiology (Bethesda, Md.: 1985), vol. 117, no. 3, pp. 239–245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Zhang, D. Xu, J. Nie, R. Han, Y. Zhai, and Y. Shi, “Comparative gene identification-58 (CGI-58) promotes autophagy as a putative lysophosphatidylglycerol acyltransferase,” The Journal of Biological Chemistry, vol. 289, no. 47, pp. 33044–33053, 2014. View at Publisher · View at Google Scholar · View at Scopus
  111. X. Feng, Y. Yuan, C. Wang et al., “Autophagy involved in lipopolysaccharide-induced foam cell formation is mediated by adipose differentiation-related protein,” Lipids in Health and Disease, vol. 13, p. 10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Kaushik and A. M. Cuervo, “AMPK-dependent phosphorylation of lipid droplet protein PLIN2 triggers its degradation by CMA,” Autophagy, vol. 12, no. 2, pp. 432–438, 2016. View at Publisher · View at Google Scholar · View at Scopus
  113. R. Singh, S. Kaushik, Y. Wang et al., “Autophagy regulates lipid metabolism,” Nature, vol. 458, no. 7242, pp. 1131–1135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Kaushik and A. M. Cuervo, “Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis,” Nature Cell Biology, vol. 17, no. 6, pp. 759–770, 2015. View at Publisher · View at Google Scholar · View at Scopus
  115. E. A. Richter and M. Hargreaves, “Exercise, GLUT4, and skeletal muscle glucose uptake,” Physiological Reviews, vol. 93, no. 3, pp. 993–1017, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. D. Kioumourtzoglou, G. W. Gould, and N. J. Bryant, “Insulin stimulates syntaxin4 SNARE complex assembly via a novel regulatory mechanism,” Molecular and Cellular Biology, vol. 34, no. 7, pp. 1271–1279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. J. A. Strauss, C. S. Shaw, H. Bradley et al., “Immunofluorescence microscopy of SNAP23 in human skeletal muscle reveals colocalization with plasma membrane, lipid droplets, and mitochondria,” Physiological Reports, vol. 4, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  118. A. Espinosa, C. Henriquez-Olguin, and E. Jaimovich, “Reactive oxygen species and calcium signals in skeletal muscle: a crosstalk involved in both normal signaling and disease,” Cell Calcium, vol. 60, no. 3, pp. 172–179, 2016. View at Publisher · View at Google Scholar · View at Scopus
  119. J. T. Lanner, J. D. Bruton, A. Katz, and H. Westerblad, “Ca(2+) and insulin-mediated glucose uptake,” Current Opinion in Pharmacology, vol. 8, no. 3, pp. 339–345, 2008. View at Publisher · View at Google Scholar · View at Scopus